Preventing the exacerbation of health disparities by iatrogenic pharmacogenomic applications: lessons from warfarin
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preventing the exacerbation of health disparities by iatrogenic pharmacogenomic applications: lessons from warfarin
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 19, Issue 11, Pages 875-881
Publisher
Future Medicine Ltd
Online
2018-06-14
DOI
10.2217/pgs-2018-0055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study
- (2017) Karla Claudio-Campos et al. Frontiers in Pharmacology
- Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and PreemptiveCYP2C9andVKORC1Genetic Testing
- (2016) A Owusu Obeng et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Admixture and ethno-specific alleles: missing links for global pharmacogenomics
- (2016) Jorge Duconge et al. PHARMACOGENOMICS
- A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics
- (2016) Jorge Duconge et al. PLoS One
- Race influences warfarin dose changes associated with genetic factors
- (2015) N. A. Limdi et al. BLOOD
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans
- (2015) Katarzyna Drozda et al. Pharmacogenetics and Genomics
- Genome-wide association study of warfarin maintenance dose in a Brazilian sample
- (2015) Esteban J Parra et al. PHARMACOGENOMICS
- Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration
- (2015) Paulo Caleb Junior Lima Santos et al. PHARMACOGENOMICS
- Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans
- (2014) R. Daneshjou et al. BLOOD
- Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
- (2014) Stuart A Scott et al. PHARMACOGENOMICS
- Exploring the Distribution of Genetic Markers of Pharmacogenomics Relevance in Brazilian and Mexican Populations
- (2014) Vania Bonifaz-Peña et al. PLoS One
- Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
- (2013) Minoli A Perera et al. LANCET
- Pharmacogenetics and Coumarin Dosing — Recalibrating Expectations
- (2013) Issam Zineh et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
- (2013) Stephen E. Kimmel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Genotype-Guided Dosing of Warfarin
- (2013) Munir Pirmohamed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomics of warfarin in populations of African descent
- (2012) Guilherme Suarez-Kurtz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients
- (2012) Alga S Ramos et al. PHARMACOGENOMICS
- Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry
- (2011) Mariana Rodrigues Botton et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenomics of Warfarin dose requirements in Hispanics☆
- (2010) Larisa H. Cavallari et al. BLOOD CELLS MOLECULES AND DISEASES
- Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing
- (2010) P Lenzini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans
- (2010) L H Cavallari et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose
- (2009) G. Suarez-Kurtz et al. BLOOD
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients
- (2008) JA Perini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations
- (2008) Alan HB Wu et al. PHARMACOGENOMICS
- VKORC1polymorphisms in Amerindian populations of Brazil
- (2008) Jamila A Perini et al. PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now